https://ir.axogeninc.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_f225e99611b8d4eb8356a1d286381376/axogeninc/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.axogeninc.com/news-events/press-releases/detail/1019/axogen-inc-reports-fourth-quarter-and-full-year-2025-financial-results Tue, 24 Feb 26 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1019/axogen-inc-reports-fourth-quarter-and-full-year-2025-financial-results https://ir.axogeninc.com/news-events/press-releases/detail/1018/axogen-inc-to-participate-in-multiple-upcoming-investor-conferences Tue, 17 Feb 26 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1018/axogen-inc-to-participate-in-multiple-upcoming-investor-conferences https://ir.axogeninc.com/news-events/press-releases/detail/1017/axogen-inc-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24-2026 Tue, 10 Feb 26 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1017/axogen-inc-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24-2026 https://ir.axogeninc.com/news-events/press-releases/detail/1016/axogen-announces-pricing-of-upsized-124-million-public-offering-of-common-stock Wed, 21 Jan 26 23:18:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1016/axogen-announces-pricing-of-upsized-124-million-public-offering-of-common-stock https://ir.axogeninc.com/news-events/press-releases/detail/1015/axogen-announces-proposed-public-offering-of-common-stock Wed, 21 Jan 26 16:09:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1015/axogen-announces-proposed-public-offering-of-common-stock https://ir.axogeninc.com/news-events/press-releases/detail/1014/axogen-inc-reports-preliminary-unaudited-revenue-for-fourth-quarter-and-full-year-2025 Mon, 12 Jan 26 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1014/axogen-inc-reports-preliminary-unaudited-revenue-for-fourth-quarter-and-full-year-2025 https://ir.axogeninc.com/news-events/press-releases/detail/1013/axogen-inc-to-participate-in-the-j-p-morgan-2026-healthcare-conference Wed, 17 Dec 25 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1013/axogen-inc-to-participate-in-the-j-p-morgan-2026-healthcare-conference https://ir.axogeninc.com/news-events/press-releases/detail/1012/axogen-announces-fda-approval-of-biologics-license-application-for-avance-acellular-nerve-allograftarwx Wed, 03 Dec 25 20:01:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1012/axogen-announces-fda-approval-of-biologics-license-application-for-avance-acellular-nerve-allograftarwx https://ir.axogeninc.com/news-events/press-releases/detail/1011/axogen-inc-to-participate-in-multiple-upcoming-investor-conferences Tue, 04 Nov 25 07:00:00 -0500 https://ir.axogeninc.com/news-events/press-releases/detail/1011/axogen-inc-to-participate-in-multiple-upcoming-investor-conferences https://ir.axogeninc.com/news-events/press-releases/detail/1010/axogen-inc-reports-third-quarter-2025-financial-results Wed, 29 Oct 25 07:00:00 -0400 https://ir.axogeninc.com/news-events/press-releases/detail/1010/axogen-inc-reports-third-quarter-2025-financial-results